Equities

agilon health inc

AGL:NYQ

agilon health inc

Actions
Health CareHealth Care Providers
  • Price (USD)1.89
  • Today's Change0.11 / 6.18%
  • Shares traded2.79m
  • 1 Year change-84.02%
  • Beta0.5012
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4889091,040
Total Receivables, Net942498293
Total Inventory------
Prepaid expenses433419
Other current assets, total6.761115
Total current assets1,4801,4511,367
Property, plant & equipment, net413321
Goodwill, net244242
Intangibles, net646855
Long term investments45176.69
Note receivable - long term------
Other long term assets878795
Total assets1,7411,6971,586
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases6.255.005.00
Other current liabilities, total738347239
Total current liabilities977535357
Total long term debt323843
Total debt394348
Deferred income tax------
Minority interest(0.82)(0.61)(0.3)
Other liabilities, total708394
Total liabilities1,079656494
SHAREHOLDERS EQUITY
Common stock4.064.124.00
Additional paid-in capital1,9872,1072,046
Retained earnings (accumulated deficit)(1327)(1064)(958)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(2.3)(5.56)--
Total equity6621,0411,092
Total liabilities & shareholders' equity1,7411,6971,586
Total common shares outstanding406412400
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.